PL414457A1 - New cellular line carcinoma mucoepidermale and its application for in vitro tests - Google Patents
New cellular line carcinoma mucoepidermale and its application for in vitro testsInfo
- Publication number
- PL414457A1 PL414457A1 PL414457A PL41445715A PL414457A1 PL 414457 A1 PL414457 A1 PL 414457A1 PL 414457 A PL414457 A PL 414457A PL 41445715 A PL41445715 A PL 41445715A PL 414457 A1 PL414457 A1 PL 414457A1
- Authority
- PL
- Poland
- Prior art keywords
- application
- vitro tests
- mucoepidermale
- new cellular
- cellular line
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Przedmiotem zgłoszenia jest nowa wyizolowana linia komórkowa, pochodząca z komórek guza ślinianki z rozpoznaniem histopatologicznym raka śluzowo - naskórkowego, wykorzystywana do badań in vitro m.in. do przeprowadzania wyciszania lub indukcji ekspresji genów, analiz funkcjonalnych określających żywotność zmodyfikowanych komórek, analiz cytotoksyczności nanokompleksów połączonych z przeciwciałem do określonych białek.The subject of the application is a new isolated cell line derived from salivary gland tumor cells with histopathological diagnosis of muco-epidermal cancer, used for in vitro tests, including for silencing or inducing gene expression, functional analyzes determining the viability of modified cells, cytotoxicity analyzes of nanocomplexes linked to the antibody to specific proteins.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL414457A PL229507B1 (en) | 2015-10-22 | 2015-10-22 | New cellular line carcinoma mucoepidermale and its application for in vitro tests |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL414457A PL229507B1 (en) | 2015-10-22 | 2015-10-22 | New cellular line carcinoma mucoepidermale and its application for in vitro tests |
Publications (2)
Publication Number | Publication Date |
---|---|
PL414457A1 true PL414457A1 (en) | 2017-04-24 |
PL229507B1 PL229507B1 (en) | 2018-07-31 |
Family
ID=58672062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL414457A PL229507B1 (en) | 2015-10-22 | 2015-10-22 | New cellular line carcinoma mucoepidermale and its application for in vitro tests |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL229507B1 (en) |
-
2015
- 2015-10-22 PL PL414457A patent/PL229507B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL229507B1 (en) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2021000704A1 (en) | Signal Regulatory Alpha Protein Antibodies and Methods of Use. (application divisional 668-2019) | |
PH12017502390A1 (en) | Constructs targeting ny-eso-1 peptide/mhc complexes and uses thereof | |
CL2018003758A1 (en) | Anti-dll3-antibody antibody conjugates and methods of use. (divisional application 201800458) | |
MX2020013169A (en) | Camptothecin conjugates. | |
MX2017012352A (en) | Constructs targeting afp peptide/mhc complexes and uses thereof. | |
CL2015000582A1 (en) | Anti-mcam antibodies and associated methods of use | |
BR112016014022A2 (en) | anti-cd3 antibodies, isolated nucleic acid, vector, host cell, anti-cd3 antibody production method, immunoconjugate, composition, use of anti-cd3 antibody, treatment methods, methods of enhancing immune function and kit | |
CO6721041A2 (en) | Anti-pcsk9 antibody and methods of use | |
EA201690617A1 (en) | COMBINING ANTI-LAG-3-ANTIBODIES AND ANTI-PD-1-ANTIBODIES FOR THE TREATMENT OF TUMORS | |
TR201904270T4 (en) | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions. | |
EA202192126A3 (en) | METHODS FOR COLLECTING MAMMALIAN CULTURES | |
UY35964A (en) | HUMAN ANTIBODIES FOR PD? 1 | |
MX2017014056A (en) | Constructs targeting hpv16-e7 peptide/mhc complexes and uses thereof. | |
ECSP13013022A (en) | FGFR1 AGONISTS AND THEIR METHODS OF USE | |
CR20150247A (en) | ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE | |
CR20140382A (en) | ANTI-LRP5 ANTIBODIES AND METHODS OF USE | |
EA201500172A1 (en) | MODIFIED POLYPEPTIDES OF THE FACTOR X AND THEIR APPLICATION | |
CU24405B1 (en) | CRY1DA1 AMINO ACID SEQUENCE VARIATIONS PROTEINS FOR LEPIDOPTERS | |
CL2019002323A1 (en) | Il-13ra2 antibody and its use. | |
PH12018500159A1 (en) | Constructs targeting psa peptide/mhc complexes and uses thereof | |
ES2721935T3 (en) | Anti-BAG3 antibodies for therapeutic use | |
TWD180565S (en) | Applicator | |
MX2016005854A (en) | Neuregulin allosteric anti-her3 antibody. | |
AR112602A1 (en) | ANTI-TrkB ANTIBODIES | |
AR088245A1 (en) | CHARACTERIZATION OF PROTEIN AND THE CHO-MIF GENE AND USE OF THE SAME |